We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Therapy Reduces Risk of Death by 42% in Study of Patients With Common Liver Cancer

News   May 14, 2020 | Original story from UCLA Health

 
Therapy Reduces Risk of Death by 42% in Study of Patients With Common Liver Cancer
 
 
Advertisement
 

RELATED ARTICLES

Data Shows Pfizer-BioNTech COVID-19 Vaccine Provides Protection From First Dose

News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

READ MORE

HER2 Breast Cancer Cells Adopt Strategy To Resist Immunotherapy

News

Findings from a study published in Nature Communications reveal how cancer cells escape death by lymphocytes through the disruption of interferon-gamma signaling.

READ MORE

Compound Repairs Degenerating Brain Cells in ALS

News

Scientists have identified a compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to the neurodegenerative disease amyotrophic lateral sclerosis (ALS)

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE